Table 1.
Rates of lymph node metastasis in early-staged clear cell carcinoma and serous adenocarcinoma
| author | year | number of patients | pT stage | metastatic rate |
|---|---|---|---|---|
| clear cell carcinoma | ||||
| Di Re[2] |
1989 |
11 |
pT1 |
9% (1/11) |
| Petru[3] |
1994 |
2 |
pT1 |
0% (0/2) |
| Onda[4] |
1996 |
16 |
pT1/2 |
31% (5/16) |
| Baiocchi[5] |
1998 |
21 |
pT1 |
5% (1/21) |
| Suzuki[6] |
2000 |
9 |
pT1 |
11% (1/9) |
| Sakuragi[7] |
2000 |
23 |
pT1/2 |
17% (4/23) |
| Negishi[8] |
2004 |
46 |
pT1 |
12% (5/42) |
| pT2 |
75% (3/4) |
|||
| Takano[9] |
2006 |
173 |
pT1a |
9% (3/36) |
| pT1c |
7% (7/99) |
|||
| pT2 |
13%(5/38) |
|||
| Harter[10] |
2007 |
7 |
pT1 |
0% (0/7) |
| Desteli[11] |
2010 |
4 |
pT1 |
0% (0/4) |
| Nomura[12] |
2010 |
36 |
pT1/2 |
6% (2/36) |
|
Subtotal |
|
348 |
|
11%(37/348) |
| Serous cystadenocarcinoma | ||||
| Di Re[2] |
1989 |
40 |
pT1 |
28% (11/40) |
| Petru[3] |
1994 |
21 |
pT1 |
38% (8/21) |
| Onda[4] |
1996 |
21 |
pT1/2 |
33% (7/21) |
| Baiocchi[5] |
1998 |
106 |
pT1 |
26% (27/106) |
| Suzuki[6] |
2000 |
13 |
pT1 |
31% (4/13) |
| Sakuragi[7] |
2000 |
25 |
pT1/2 |
8% (2/25) |
| Morice[13] |
2003 |
26 |
pT1 |
31% (8/26) |
| Negishi[8] |
2004 |
35 |
pT1 |
4% (1/24) |
| pT2 |
36% (4/11) |
|||
| Harter[10] |
2007 |
13 |
pT1 |
15% (2/13) |
| Desteli[11] |
2010 |
7 |
pT1 |
14% (1/7) |
| Nomura[12] |
2010 |
12 |
pT1/2 |
50% (6/12) |
| Subtotal | 319 | 25%(81/319) | ||